News

Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Sanofi SA SNY announced plans to acquire Blueprint Medicines for $9.5 billion. Blueprint Medicines shares jumped 26.9% to ...
Silexion Therapeutics Corp (SLXN)’s RNAi Therapy Blocks 90% of Colorectal Tumors
Silexion Therapeutics Corp (NASDAQ:SLXN) has announced breakthrough preclinical results for its next-generation RNA ...
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; ...
Cbonds13d
Silexion Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
— We have everything you need: full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...
Hosted on MSN14d
Silexion Therapeutics Receives Nasdaq Delisting Notice
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value ...
WBTW16d
PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
The precision oncology landscape is experiencing a potential breakthrough with Silexion Therapeutics' innovative approach to addressing KRAS-driven cancers. KRAS mutations represent one of the ...
Mena FN16d
PESG Research Report: A Review Of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
(MENAFN- GlobeNewsWire - Nasdaq) New Report Covers Silexion Therapeutics, A Unique Precision Oncology Player New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of ...
Finanznachrichten17d
Silexion Therapeutics Corp: Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204's Potential Impact on Colorectal and Lung Cancer
Zeit Aktuelle Nachrichten 16:15 Silexion Therapeutics Corp - 8-K, Current Report 15:18 Silexion reports breakthrough in KRAS-driven cancer therapy 15:18 Silexion Therapeutics Corp: Silexion ...